2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).
about
Recent Development of the Second and Third Generation Irreversible Epidermal Growth Factor Receptor Inhibitors.MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines.Biomass-involved synthesis of N-substituted benzofuro[2,3-d]pyrimidine-4-amines and biological evaluation as novel EGFR tyrosine kinase inhibitors.Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma.
P2860
2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
2,4-Diarylamino-pyrimidines as ...... g IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).
@en
type
label
2,4-Diarylamino-pyrimidines as ...... g IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).
@en
prefLabel
2,4-Diarylamino-pyrimidines as ...... g IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).
@en
P2093
P1476
2,4-Diarylamino-pyrimidines as ...... g IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).
@en
P2093
Huimin Cheng
Jeff Smaill
Linjiang Tong
Shingpan Chan
Xiaomei Ren
Xiaoyun Lu
P304
P356
10.1016/J.BMCL.2015.07.089
P407
P577
2015-07-30T00:00:00Z